Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.
Τίτλος | Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Bradley, J. S., Roilides E., Broadhurst H., Cheng K., Huang L-M., MasCasullo V., Newell P., Stone G. G., Tawadrous M., Wajsbrot D., Yates K., & Gardner A. |
Journal | Pediatr Infect Dis J |
Volume | 38 |
Issue | 9 |
Pagination | 920-928 |
Date Published | 2019 09 |
ISSN | 1532-0987 |
Λέξεις κλειδιά | Administration, Intravenous, Adolescent, Anti-Bacterial Agents, Azabicyclo Compounds, Ceftazidime, Child, Child, Preschool, Drug Combinations, Drug Resistance, Multiple, Bacterial, Escherichia coli, Female, Humans, Infant, Male, Single-Blind Method, Urinary Tract Infections |
Abstract | BACKGROUND: Ceftazidime-avibactam is effective and well tolerated in adults with complicated urinary tract infection (cUTI), but has not been evaluated in children with cUTI. |
DOI | 10.1097/INF.0000000000002395 |
Alternate Journal | Pediatr Infect Dis J |
PubMed ID | 31335570 |